The Decrease in Serum sRAGE Levels Upon Smoking is Associated with Activated Neutrophils

Lung. 2022 Dec;200(6):687-690. doi: 10.1007/s00408-022-00585-4. Epub 2022 Oct 25.

Abstract

The serum level of the soluble Receptor for Advanced Glycation End-products (sRAGE) is a promising blood biomarker for the development, severity, and progression of chronic obstructive pulmonary disease (COPD). However, cigarette smoking causes a nearly instant drop in circulating sRAGE levels, strongly impacting on the variability in sRAGE levels. In the current study, we investigated the possible mechanism behind the sudden drop in sRAGE upon smoking. We showed that the number of activated neutrophils in blood significantly increases within two hours upon smoking three cigarettes within one hour. Furthermore, an increased expression of the leukocyte activation marker CD11b, which is a known ligand for RAGE, was observed upon smoking. Additionally, the in vitro activation of neutrophils increased their capacity to bind sRAGE. Together, these data indicate that smoking activates neutrophils in the circulation with concomitant upregulation of the RAGE ligand CD11b, leading to reduced levels of sRAGE in serum.

Keywords: Biomarkers; CD11b; COPD; Cigarette smoke; sRAGE.

MeSH terms

  • Biomarkers
  • Humans
  • Ligands
  • Neutrophils* / metabolism
  • Receptor for Advanced Glycation End Products / metabolism
  • Receptors, Immunologic*
  • Smoking / adverse effects

Substances

  • Receptor for Advanced Glycation End Products
  • Ligands
  • Receptors, Immunologic
  • Biomarkers